Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
about
Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.The Future of Continuous Glucose Monitoring.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors.Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.Clinical Use of Continuous Glucose Monitoring in Pediatrics.12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes.Type 1 diabetes: where are we in 2017?Model-Fusion-Based Online Glucose Concentration Predictions in People with Type 1 Diabetes.A Personalized Week-to-Week Updating Algorithm to Improve Continuous Glucose Monitoring Performance.Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.Hope vs hype: where are we in type 1 diabetes?Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes.Event-Triggered Model Predictive Control For Embedded Artificial Pancreas Systems.10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27-29, 2017, Warsaw, Poland.The artificial pancreas in 2017: The year of transition from research to clinical practice.Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.Will the First Approved Automated Insulin Delivery System Be a Game-Changer in Type 1 Diabetes Management?Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus.Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.Relevance of Bolus Calculators in Current Hybrid Closed Loop Systems.Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small AdultsClosed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialAdvances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice GuidelinesVariables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the "On-Board" ConceptArtificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 DiabetesEffect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol
P2860
Q33454851-49E750A4-54DE-43FF-AC2F-2BA1EE07FA46Q33786175-EF2FC7E6-62BE-4EE5-95A3-8ECA785DE12DQ38674274-8CB4916F-1E96-4E76-B1D4-608EC30567A3Q39413453-97750C32-7808-4E81-A00F-0C749C1E6AA0Q41494516-D9ADFE75-5E5E-4C34-BB02-BFB3A2D1A1EDQ41776501-B24D163E-ADE0-4EFF-9885-97959FB004D2Q42008289-31B8C39F-2FA5-4D79-8287-8D92330A4554Q42245193-8A2BC063-2595-4A21-B604-D068E54E5E40Q42696179-147853E9-5328-41F0-84BA-880795DCC14BQ46726172-C8260A2F-F7B6-4668-B966-59B835B264FAQ47103537-5D564391-98BA-43BC-909B-173A4D46AA93Q47158147-A5063DFC-E4BD-4FF1-B6A2-D32C1F61494CQ47220688-B5580CAA-C16F-4C49-B4B0-A469F8B14389Q47443566-BFC49506-07D9-49FC-A09A-A3C84B0C2C77Q47553121-7E108DB6-C64B-40D4-BD8B-C3845E2E4DBDQ47562138-8F1B68AB-315C-4CC8-AF92-C7F956AE232CQ47721261-50F1A9B6-26BE-41AB-A329-4989F46F8EB7Q47831910-75E39718-06DD-4089-A811-044B73F414A3Q48556396-0BFF8FC9-28F4-41D8-B9DE-7B2F7F9D83E0Q49501336-45D956B2-5C16-4A48-94B8-C5AA2DAD1F64Q50047761-EFE41358-BB09-4632-8A39-D1747BCAB1A6Q50347897-65DC664F-28BC-4BBA-8847-26A61C70328CQ52586603-1ECAD516-6D0E-4052-8E10-8B872FDFEA32Q52664471-374058FD-81C2-475C-9F84-EE8E5FC10747Q53280517-248B3A77-DAEE-4390-B67B-60FD3E7D7AE9Q53714062-36E97A93-1A2A-4068-BFEA-62CCFBFB7998Q55361914-194776DE-0B6A-456D-96CC-AD928247B92DQ55398504-1C4B1DA7-3528-4016-AC67-FE44F3F0D194Q57171958-B1A4D828-7E4D-49BC-9E29-C420D003F631Q57190370-E1FB3514-E865-462B-97F5-C44F450500ABQ57483085-4545F674-3D8D-4352-AF80-D734420295E5Q58604241-D4A3AE8A-32CE-4FB7-B74A-CE424C34EB61Q58701212-5F804EB0-EB93-4788-978B-67D2AE51F2A1Q58777180-004D7651-3FEA-4547-BC23-3908DF732742Q58786095-85F57E27-8660-444C-9C78-0C88D3F0A3A2
P2860
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@ast
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@en
type
label
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@ast
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@en
prefLabel
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@ast
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@en
P2093
P2860
P356
P1476
Glucose Outcomes with the In-H ...... nd Adults with Type 1 Diabetes
@en
P2093
Anirban Roy
Benyamin Grosman
Bruce A Buckingham
Bruce W Bode
Francine R Kaufman
Jacob Ilany
Richard M Bergenstal
Robert H Slover
Ronald L Brazg
P2860
P304
P356
10.1089/DIA.2016.0421
P577
2017-01-30T00:00:00Z